March 13, 2016
Patheon Solubility Enhancement Services approaches BCS II drug substance solubility issues a fundamentally different way. By evaluating your molecule’s physiochemical characteristics in advance, we identify the solubility enhancement technologies most likely to work, before any work is done. That helps eliminate rework and worry later on — and saves you time and money.
Marshall Crew, Ph.D, partners with Pharmaceutical Technology magazine to discuss optimal development programs for molecules of various solubility level, and how it affects future planning.